Value through Innovation27 July 2016

Clinical Study Results

  • DULCOLAX ® - Constipation
    Clinical Study Number 122.56
    Study Indication Constipation
    Product DULCOLAX ®
    Generic Name Bisacodyl
    Lab Code
    Clinical Phase IIIb
    Study Title

    A randomised, double-blind, placebo-controlled, parallel group study to assess the efficacy and safety of 4 weeks with bisacodyl (Dulcolax®) tablets 10mg administered orally, once daily, in patients with functional constipation.

    Study Document Trial synopsis 122.56_DS_DR english
  • DULCOLAX ® - Constipation
    Clinical Study Number 122.52
    Study Indication Constipation
    Product DULCOLAX ®
    Generic Name Bisacodyl
    Lab Code
    Clinical Phase IIIb
    Study Title

    Comparative efficacy and tolerability of bisacodyl sugar coated tablets, simeticone chewing tablets and the combination of both in the treatment of constipation and bloatedness: an open, randomised, parallel group trial

    Study Document Trial synopsis 122.52_CO english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.